Sonoma Pharmaceuticals Inc Quick Ratio (SNOA) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Sonoma Pharmaceuticals Inc   (NASDAQ: SNOA)

Sonoma Pharmaceuticals Inc 's Quick Ratio

SNOA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Sonoma Pharmaceuticals Inc 's Cash & cash equivalent grew by 122.51 % in the Q1 2026 sequentially, faster than Current Liabilities, this led to improvement in Sonoma Pharmaceuticals Inc 's Quick Ratio to 0.98, Quick Ratio remained below Sonoma Pharmaceuticals Inc average.

Within Medical Equipment & Supplies industry 125 other companies have achieved higher Quick Ratio than Sonoma Pharmaceuticals Inc in first quarter 2026. While Quick Ratio total ranking has improved so far during the Q1 2026 to 2139, from total ranking in the fourth quarter 2026 at 2675.

Explain Quick Ratio?
How much Cash & cash equivalents SNOA´s has?
What are SNOA´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SNOA Quick Ratio (Jun 30 2026)
Q1		 (Mar 31 2026)
Q4		 (Dec 31 2025)
Q3		 (Sep 30 2025)
Q2		 (Jun 30 2025)
Q1
Y / Y Current Liabilities Change 12.36 % 17.97 % 10.14 % 30.61 % 29.25 %
Y / Y Cash & cash equivalent Change 48.07 % -55.36 % 71.8 % -25.58 % 39.24 %
Quick Ratio MRQ 0.98 0.5 1.31 0.7 0.74
SNOA's Total Ranking # 2139 # 2675 # 2672 # 2048 # 2720
Seq. Current Liabilities Change 12.73 % 17.97 % -5.23 % -10.85 % 18.36 %
Seq. Cash & cash equivalent Change 122.51 % -55.36 % 77.07 % -15.81 % -32.92 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 126
Healthcare Sector # 697
Overall Market # 2405


Quick Ratio Statistics
High Average Low
6.55 1.53 0.5
(Mar 31 2017)  




Financial Statements
Sonoma Pharmaceuticals Inc 's Current Liabilities $ 5 Millions Visit SNOA's Balance sheet
Sonoma Pharmaceuticals Inc 's Cash & cash equivalent $ 5 Millions Visit SNOA's Balance sheet
Source of SNOA's Sales Visit SNOA's Sales by Geography


Cumulative Sonoma Pharmaceuticals Inc 's Quick Ratio

SNOA's Quick Ratio for the trailling 12 Months

SNOA Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 17.06 % 21.67 % 19.75 % 17.17 % 10.72 %
Y / Y Cash & cash equivalent TTM Growth -0.24 % -4.98 % 34.55 % 11.22 % 38.64 %
Quick Ratio TTM 0.86 0.8 1 0.89 1.01
Total Ranking TTM # 1473 # 1212 # 1135 # 1132 # 1463
Seq. Current Liabilities TTM Growth 3.31 % 4.24 % 2.22 % 6.34 % 7.37 %
Seq. Cash & cash equivalent TTM Growth 12.02 % -17.11 % 14.83 % -6.44 % 6.7 %

Quick ratio ranking by company, industry and sector >> Back to SNOA Financial Strength Comparisons >> Go to Compare SNOA Quick Ratio to its Competitors

On the trailing twelve months basis SNOA Cash & cash equivalent soared by 48.07 % in Q1 2026 year on year, faster than Current Liabilities, this led to increase in in Sonoma Pharmaceuticals Inc 's Quick Ratio to 0.86, Quick Ratio remained below SNOA average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 220 other companies have achieved higher Quick Ratio than Sonoma Pharmaceuticals Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending fourth quarter 2026 at 4709.

Explain Quick Ratio?
How much Cash & cash equivalents SNOA´s has?
What are SNOA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 221
Healthcare Sector # 996
Within the Market # 2139


trailing twelve months Quick Ratio Statistics
High Average Low
4.51 1.47 0.77
(Dec 31 2017)   (Dec 31 2014)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Neuraxis Inc   2.69 $ 8.342  Millions$ 3.096  Millions
Edwards Lifesciences Corporation  2.68 $ 4,291.700  Millions$ 1,604.100  Millions
Modular Medical Inc  2.63 $ 3.920  Millions$ 1.489  Millions
Co diagnostics Inc   2.55 $ 7.299  Millions$ 2.863  Millions
Staar Surgical Co  2.47 $ 181.489  Millions$ 73.394  Millions
Electromed Inc   2.35 $ 20.450  Millions$ 8.714  Millions
EBR Systems, Inc.  2.18 $ 113.533  Millions$ 52.023  Millions
Medinotec Inc   2.15 $ 2.519  Millions$ 1.171  Millions
Atricure Inc   2.05 $ 167.786  Millions$ 81.916  Millions
Tactile Systems Technology Inc   1.83 $ 69.853  Millions$ 38.253  Millions
Tandem Diabetes Care Inc   1.80 $ 455.996  Millions$ 253.005  Millions
Inspire Medical Systems inc   1.79 $ 127.761  Millions$ 71.282  Millions
Warby Parker Inc   1.79 $ 292.674  Millions$ 163.480  Millions
Capsovision Inc   1.76 $ 9.077  Millions$ 5.158  Millions
Anika Therapeutics Inc   1.73 $ 38.412  Millions$ 22.147  Millions
Genedx Holdings Corp   1.71 $ 132.548  Millions$ 77.648  Millions
Beta Bionics Inc   1.70 $ 44.318  Millions$ 26.017  Millions
Merit Medical Systems Inc  1.70 $ 450.906  Millions$ 264.933  Millions
Seastar Medical Holding Corp  1.60 $ 6.959  Millions$ 4.353  Millions
Tela Bio Inc   1.59 $ 30.424  Millions$ 19.080  Millions
Conexeu Sciences Inc   1.55 $ 1.971  Millions$ 1.272  Millions
Inogen Inc   1.49 $ 105.539  Millions$ 70.864  Millions
Dariohealth Corp   1.49 $ 14.254  Millions$ 9.578  Millions
Myomo Inc   1.45 $ 15.686  Millions$ 10.805  Millions
Envoy Medical Inc   1.43 $ 19.679  Millions$ 13.807  Millions
Nephros Inc   1.40 $ 4.697  Millions$ 3.344  Millions
Envista Holdings Corporation  1.39 $ 1,125.600  Millions$ 807.300  Millions
Medtronic Plc  1.36 $ 16,068.000  Millions$ 11,799.000  Millions
Sanara Medtech Inc   1.31 $ 16.421  Millions$ 12.494  Millions
Globus Medical Inc   1.24 $ 595.142  Millions$ 479.347  Millions

Date modified: 2026-09-05T15:31:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.